Hologic, Inc. (HOLX)
USD 58.46
(-4.59%)
USD 58.46
(-4.59%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 374.4 Million USD | 420.17% |
| 2023 | 95.7 Million USD | -80.22% |
| 2022 | 483.9 Million USD | -73.91% |
| 2021 | 1.85 Billion USD | -20.66% |
| 2020 | 2.33 Billion USD | -4.7% |
| 2019 | 2.45 Billion USD | -6.99% |
| 2018 | 2.63 Billion USD | -5.2% |
| 2017 | 2.78 Billion USD | -0.53% |
| 2016 | 2.79 Billion USD | -11.12% |
| 2015 | 3.14 Billion USD | -10.75% |
| 2014 | 3.52 Billion USD | -11.33% |
| 2013 | 3.97 Billion USD | -11.03% |
| 2012 | 4.46 Billion USD | 475.78% |
| 2011 | 776.24 Million USD | -16.78% |
| 2010 | 932.79 Million USD | -42.07% |
| 2009 | 1.61 Billion USD | -23.52% |
| 2008 | 2.1 Billion USD | 2460.03% |
| 2007 | -89.2 Million USD | -361.13% |
| 2006 | 34.16 Million USD | 129.97% |
| 2005 | -113.99 Million USD | -69.16% |
| 2004 | -67.38 Million USD | -56.18% |
| 2003 | -43.14 Million USD | -0.14% |
| 2002 | -43.08 Million USD | -337.46% |
| 2001 | 18.14 Million USD | 595.21% |
| 2000 | 2.61 Million USD | 107.37% |
| 1999 | -35.4 Million USD | 20.63% |
| 1998 | -44.6 Million USD | -59.29% |
| 1997 | -28 Million USD | -6.46% |
| 1996 | -26.3 Million USD | -396.23% |
| 1995 | -5.3 Million USD | -51.43% |
| 1994 | -3.5 Million USD | 47.76% |
| 1993 | -6.7 Million USD | -179.17% |
| 1992 | -2.4 Million USD | 73.33% |
| 1991 | -9 Million USD | 32.84% |
| 1990 | -13.4 Million USD | -1240.0% |
| 1989 | -1 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 120.1 Million USD | -69.09% |
| 2024 Q4 | 374.4 Million USD | 211.74% |
| 2024 Q2 | 388.5 Million USD | -39.85% |
| 2024 Q1 | 645.9 Million USD | 574.92% |
| 2023 Q3 | 56.1 Million USD | -76.79% |
| 2023 Q2 | 241.7 Million USD | -37.3% |
| 2023 Q1 | 385.5 Million USD | -33.77% |
| 2023 FY | 95.7 Million USD | -80.22% |
| 2023 Q4 | 95.7 Million USD | 70.59% |
| 2022 FY | 483.9 Million USD | -73.91% |
| 2022 Q3 | 469.2 Million USD | -41.52% |
| 2022 Q4 | 582.1 Million USD | 24.06% |
| 2022 Q2 | 802.3 Million USD | -52.02% |
| 2022 Q1 | 1.67 Billion USD | -9.85% |
| 2021 Q1 | 1.91 Billion USD | -18.11% |
| 2021 Q2 | 1.95 Billion USD | 2.23% |
| 2021 Q4 | 1.85 Billion USD | -19.83% |
| 2021 Q3 | 2.31 Billion USD | 18.21% |
| 2021 FY | 1.85 Billion USD | -20.66% |
| 2020 Q1 | 2.72 Billion USD | 10.93% |
| 2020 Q2 | 2.77 Billion USD | 2.0% |
| 2020 Q3 | 2.57 Billion USD | -7.33% |
| 2020 Q4 | 2.33 Billion USD | -9.12% |
| 2020 FY | 2.33 Billion USD | -4.7% |
| 2019 Q4 | 2.45 Billion USD | -7.32% |
| 2019 FY | 2.45 Billion USD | -6.99% |
| 2019 Q2 | 2.73 Billion USD | -3.78% |
| 2019 Q1 | 2.83 Billion USD | 7.61% |
| 2019 Q3 | 2.64 Billion USD | -3.08% |
| 2018 FY | 2.63 Billion USD | -5.2% |
| 2018 Q2 | 2.76 Billion USD | 2.63% |
| 2018 Q4 | 2.63 Billion USD | -2.12% |
| 2018 Q3 | 2.69 Billion USD | -2.36% |
| 2018 Q1 | 2.68 Billion USD | -3.34% |
| 2017 Q4 | 2.78 Billion USD | 4.7% |
| 2017 FY | 2.78 Billion USD | -0.53% |
| 2017 Q1 | 2.67 Billion USD | -4.29% |
| 2017 Q2 | 2.17 Billion USD | -18.79% |
| 2017 Q3 | 2.65 Billion USD | 22.24% |
| 2016 Q4 | 2.79 Billion USD | -6.16% |
| 2016 Q3 | 2.98 Billion USD | -3.52% |
| 2016 Q2 | 3.08 Billion USD | 3.6% |
| 2016 Q1 | 2.98 Billion USD | -5.24% |
| 2016 FY | 2.79 Billion USD | -11.12% |
| 2015 Q4 | 3.14 Billion USD | 2.94% |
| 2015 FY | 3.14 Billion USD | -10.75% |
| 2015 Q2 | 3.26 Billion USD | -4.15% |
| 2015 Q3 | 3.05 Billion USD | -6.48% |
| 2015 Q1 | 3.41 Billion USD | -3.27% |
| 2014 Q1 | 3.85 Billion USD | -4.08% |
| 2014 Q2 | 3.78 Billion USD | -1.82% |
| 2014 Q3 | 3.63 Billion USD | -3.99% |
| 2014 FY | 3.52 Billion USD | -11.33% |
| 2014 Q4 | 3.52 Billion USD | -2.92% |
| 2013 Q3 | 4.04 Billion USD | -4.99% |
| 2013 Q1 | 4.31 Billion USD | -3.45% |
| 2013 Q2 | 4.25 Billion USD | -1.46% |
| 2013 Q4 | 4.01 Billion USD | -0.58% |
| 2013 FY | 3.97 Billion USD | -11.03% |
| 2012 Q4 | 4.46 Billion USD | 602.15% |
| 2012 FY | 4.46 Billion USD | 475.78% |
| 2012 Q3 | 636.54 Million USD | -5.27% |
| 2012 Q2 | 671.93 Million USD | -5.88% |
| 2012 Q1 | 713.92 Million USD | -8.03% |
| 2011 Q2 | 879.65 Million USD | 6.35% |
| 2011 Q1 | 827.12 Million USD | -11.33% |
| 2011 Q3 | 856.65 Million USD | -2.61% |
| 2011 FY | 776.24 Million USD | -16.78% |
| 2011 Q4 | 776.24 Million USD | -9.39% |
| 2010 Q1 | 1.16 Billion USD | -27.43% |
| 2010 Q2 | 1.02 Billion USD | -12.07% |
| 2010 Q3 | 938.66 Million USD | -8.65% |
| 2010 Q4 | 932.79 Million USD | -0.63% |
| 2010 FY | 932.79 Million USD | -42.07% |
| 2009 Q4 | 1.61 Billion USD | -8.67% |
| 2009 FY | 1.61 Billion USD | -23.52% |
| 2009 Q2 | 1.89 Billion USD | -5.11% |
| 2009 Q1 | 1.99 Billion USD | -5.01% |
| 2009 Q3 | 1.76 Billion USD | -7.09% |
| 2008 Q4 | 2.1 Billion USD | 30.16% |
| 2008 FY | 2.1 Billion USD | 2460.03% |
| 2008 Q3 | 1.61 Billion USD | -6.48% |
| 2008 Q1 | 1.88 Billion USD | 2209.69% |
| 2008 Q2 | 1.72 Billion USD | -8.1% |
| 2007 Q2 | -45.64 Million USD | -564.76% |
| 2007 Q3 | -84.2 Million USD | -84.45% |
| 2007 FY | -89.2 Million USD | -361.13% |
| 2007 Q4 | -89.2 Million USD | -5.94% |
| 2007 Q1 | 9.82 Million USD | -71.25% |
| 2006 Q2 | -108.28 Million USD | -14.57% |
| 2006 Q3 | -52.36 Million USD | 51.64% |
| 2006 FY | 34.16 Million USD | 129.97% |
| 2006 Q4 | 34.16 Million USD | 165.23% |
| 2006 Q1 | -94.51 Million USD | 17.09% |
| 2005 Q3 | -101.65 Million USD | -7.03% |
| 2005 FY | -113.99 Million USD | -69.16% |
| 2005 Q4 | -113.99 Million USD | -12.14% |
| 2005 Q1 | -71.87 Million USD | -6.66% |
| 2005 Q2 | -94.98 Million USD | -32.15% |
| 2004 Q1 | -43.16 Million USD | -0.03% |
| 2004 FY | -67.38 Million USD | -56.18% |
| 2004 Q4 | -67.38 Million USD | -21.61% |
| 2004 Q3 | -55.41 Million USD | -1.78% |
| 2004 Q2 | -54.44 Million USD | -26.14% |
| 2003 Q3 | -37.78 Million USD | -29.77% |
| 2003 Q2 | -29.11 Million USD | 28.45% |
| 2003 Q1 | -40.68 Million USD | 5.57% |
| 2003 Q4 | -43.14 Million USD | -14.21% |
| 2003 FY | -43.14 Million USD | -0.14% |
| 2002 Q1 | -988 Thousand USD | -105.45% |
| 2002 Q4 | -43.08 Million USD | -998.06% |
| 2002 Q3 | -3.92 Million USD | -270.24% |
| 2002 FY | -43.08 Million USD | -337.46% |
| 2002 Q2 | 2.3 Million USD | 333.3% |
| 2001 Q2 | 10.42 Million USD | 144.11% |
| 2001 FY | 18.14 Million USD | 595.21% |
| 2001 Q4 | 18.14 Million USD | 11.77% |
| 2001 Q3 | 16.23 Million USD | 55.71% |
| 2001 Q1 | 4.27 Million USD | 63.64% |
| 2000 Q2 | -36.31 Million USD | -1.71% |
| 2000 Q4 | 2.61 Million USD | 107.75% |
| 2000 FY | 2.61 Million USD | 107.37% |
| 2000 Q1 | -35.7 Million USD | -0.85% |
| 2000 Q3 | -33.68 Million USD | 7.22% |
| 1999 Q3 | -37.3 Million USD | -6.27% |
| 1999 FY | -35.4 Million USD | 20.63% |
| 1999 Q4 | -35.4 Million USD | 5.09% |
| 1999 Q2 | -35.1 Million USD | 23.03% |
| 1999 Q1 | -45.6 Million USD | -2.24% |
| 1998 Q4 | -44.6 Million USD | -0.22% |
| 1998 Q3 | -44.5 Million USD | -3.73% |
| 1998 Q1 | -45.2 Million USD | -61.43% |
| 1998 FY | -44.6 Million USD | -59.29% |
| 1998 Q2 | -42.9 Million USD | 5.09% |
| 1997 Q3 | -33.3 Million USD | 21.83% |
| 1997 Q4 | -28 Million USD | 15.92% |
| 1997 FY | -28 Million USD | -6.46% |
| 1997 Q1 | -30.5 Million USD | -15.97% |
| 1997 Q2 | -42.6 Million USD | -39.67% |
| 1996 FY | -26.3 Million USD | -396.23% |
| 1996 Q4 | -26.3 Million USD | 10.54% |
| 1996 Q3 | -29.4 Million USD | 47.22% |
| 1996 Q2 | -55.7 Million USD | -813.11% |
| 1996 Q1 | -6.1 Million USD | -15.09% |
| 1995 Q3 | -3.7 Million USD | 49.32% |
| 1995 FY | -5.3 Million USD | -51.43% |
| 1995 Q1 | -6.1 Million USD | -74.29% |
| 1995 Q4 | -5.3 Million USD | -43.24% |
| 1995 Q2 | -7.3 Million USD | -19.67% |
| 1994 Q3 | -2 Million USD | 57.45% |
| 1994 FY | -3.5 Million USD | 47.76% |
| 1994 Q2 | -4.7 Million USD | -6.82% |
| 1994 Q1 | -4.4 Million USD | 34.33% |
| 1994 Q4 | -3.5 Million USD | -75.0% |
| 1993 FY | -6.7 Million USD | -179.17% |
| 1993 Q2 | -3.5 Million USD | 0.0% |
| 1993 Q3 | -6.3 Million USD | -80.0% |
| 1993 Q4 | -6.7 Million USD | -6.35% |
| 1992 Q1 | -4.8 Million USD | 46.67% |
| 1992 Q2 | -2 Million USD | 58.33% |
| 1992 FY | -2.4 Million USD | 73.33% |
| 1992 Q4 | -2.4 Million USD | 41.46% |
| 1992 Q3 | -4.1 Million USD | -105.0% |
| 1991 FY | -9 Million USD | 32.84% |
| 1991 Q4 | -9 Million USD | 0.0% |
| 1990 Q4 | -13.4 Million USD | 0.0% |
| 1990 Q2 | -9.7 Million USD | 0.0% |
| 1990 FY | -13.4 Million USD | -1240.0% |
| 1989 Q4 | -1 Million USD | 0.0% |
| 1989 FY | -1 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | -14406.005% |
| AngioDynamics, Inc. | -70.14 Million USD | 633.774% |
| AtriCure, Inc. | -9.81 Million USD | 3914.181% |
| Avinger, Inc. | 10.12 Million USD | -3599.605% |
| Azenta, Inc. | -618.47 Million USD | 160.536% |
| BioLife Solutions, Inc. | 7.25 Million USD | -5062.002% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 84.708% |
| Daxor Corporation | 755.65 Thousand USD | -49446.158% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | 25569.388% |
| Femasys Inc. | -15.01 Million USD | 2593.474% |
| GlucoTrack, Inc. | -4.29 Million USD | 8815.084% |
| Harvard Bioscience, Inc. | 38.49 Million USD | -872.72% |
| ICU Medical, Inc. | 1.45 Billion USD | 74.188% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 114.074% |
| KORU Medical Systems, Inc. | -7.03 Million USD | 5420.358% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | 7336.181% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 8832.469% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 8832.469% |
| Masimo Corporation | 804 Million USD | 53.433% |
| Microbot Medical Inc. | -2.28 Million USD | 16477.953% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | 4001.73% |
| Merit Medical Systems, Inc. | 302.22 Million USD | -23.882% |
| Nephros, Inc. | -2.47 Million USD | 15251.76% |
| NovoCure Limited | 355.42 Million USD | -5.34% |
| NEXGEL, Inc. | 98 Thousand USD | -381940.816% |
| NEXGEL, Inc. | 98 Thousand USD | -381940.816% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | -533.985% |
| OraSure Technologies, Inc. | -276.9 Million USD | 235.21% |
| Pro-Dex, Inc. | 10.91 Million USD | -3329.828% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 1163.002% |
| Predictive Oncology Inc. | -5.87 Million USD | 6476.189% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | -12259.768% |
| QuidelOrtho Corporation | 2.49 Billion USD | 84.995% |
| Repligen Corporation | -39.51 Million USD | 1047.392% |
| Sanara MedTech Inc. | 6.64 Million USD | -5534.401% |
| STAAR Surgical Company | -147.2 Million USD | 354.341% |
| Sharps Technology, Inc. | -3.01 Million USD | 12526.533% |
| Utah Medical Products, Inc. | -92.52 Million USD | 504.643% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 80.947% |
| Jin Medical International Ltd. | -2.81 Million USD | 13393.057% |